PRIMARY TESTICULAR LYMPHOMA
NCT06964841 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2025-05-09
Summary
742 / 5.000 A 57-year-old male: Denies chronic degenerative, allergic, traumatic, transfusional, or surgical complications. He denies a family history of testicular cancer or abnormalities in testicular descent.
The patient presented with an enlarged right testicle that had been present for 1 month. He saw his family doctor, who prescribed antibiotic and analgesic treatment, without improvement, and was referred to our service. Upon examination, the right testicle was palpable, nontender, slightly enlarged, indurated, with nodulations measuring 0.5 cm in diameter, and free spermatozoa.
The left testicle was normal.
He underwent radical orchiectomy, which revealed renal testicular lymphoma.
Conditions
- Testicular Lymphoma
Sponsors & Collaborators
-
Instituto Mexicano del Seguro Social
lead OTHER_GOV
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-01
- Primary Completion
- 2025-03-28
- Completion
- 2025-03-29
Countries
- Mexico
Study Locations
More Related Trials
-
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
NCT05683171 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma
NCT00944567 ·Status: COMPLETED
-
Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors
NCT00001301 ·Status: COMPLETED
-
Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma
NCT00994643 ·Status: COMPLETED ·Phase: PHASE2
-
Transplantation After Complete Response In Patients With T-cell Lymphoma
NCT05444712 ·Status: RECRUITING ·Phase: NA
-
Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma
NCT00210379 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma
NCT05459571 ·Status: COMPLETED ·Phase: PHASE2
-
Lymphoma in the Orbit
NCT01302912 ·Status: UNKNOWN
-
Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma
NCT00054639 ·Status: COMPLETED ·Phase: PHASE2
-
Exosomes and Immunotherapy in Non-Hodgkin B-cell Lymphomas
NCT03985696 ·Status: COMPLETED ·Phase: NA
-
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
NCT07121946 ·Status: RECRUITING ·Phase: PHASE1
-
Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
NCT00896493 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab and Pembrolizumab With or Without Lenalidomide in Treating Patients With Relapsed Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
NCT02446457 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
NCT04670874 ·Status: RECRUITING
-
Mediastinal Grey Zone Lymphoma From the LYSA
NCT03037177 ·Status: COMPLETED
-
Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
NCT00004112 ·Status: COMPLETED ·Phase: PHASE3
-
Maintenance Hormonal Therapy and DLBCL
NCT06355401 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
NCT00058461 ·Status: TERMINATED ·Phase: PHASE2
-
An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma
NCT03968315 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Lenalidomide Maintenance Post-debulking in Advanced CTCL
NCT01098656 ·Status: TERMINATED ·Phase: PHASE3
-
Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas
NCT00877214 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas
NCT00001237 ·Status: COMPLETED ·Phase: PHASE2
-
Lenalidomide in Combination With Rituximab in Treating Participants With Stage III/IV Indolent Non-Hodgkin Lymphoma
NCT00695786 ·Status: COMPLETED ·Phase: PHASE2
-
Tislelizumab Combined Treatment in Refractory Extranodal NK/T-cell Lymphoma
NCT05058755 ·Status: COMPLETED ·Phase: NA
-
Study of Prognostic Factors in Adult Lymphoblastic Lymphoma
NCT03571997 ·Status: UNKNOWN